These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2468005)

  • 1. [Immunologic defense mechanism of non-antibody-dependent complement reactions].
    Nomoto K
    Nihon Rinsho; 1988 Sep; 46(9):1949-54. PubMed ID: 2468005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of membrane molecules in complement system].
    Okada N
    Rinsho Byori; 1991 Sep; Suppl 91():129-39. PubMed ID: 1721938
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S; Tamura N; Fujita T
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complement: mechanisms of activation, functions, analysis].
    Dessaint JP; Wattre P; Santoro F; Capron A
    Lille Med; 1979; 24(7):551-8. PubMed ID: 397392
    [No Abstract]   [Full Text] [Related]  

  • 5. The human alternative complement pathway: biology and immunopathology of activation and regulation.
    Kazatchkine MD; Nydegger UE
    Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the immunochemical studies of complement--including the establishment of nomenclature of complement proteins].
    Inai S
    Nihon Rinsho; 1979 May; 37(5):923-9. PubMed ID: 381722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complement regulatory membrane factors in experimental animal models].
    Okada N
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):631-3. PubMed ID: 8963768
    [No Abstract]   [Full Text] [Related]  

  • 9. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.
    Kameyoshi Y; Matsushita M; Okada H
    Immunology; 1989 Dec; 68(4):439-44. PubMed ID: 2481641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological role of the complement system and the clinical importance of complement measurements.
    Füst G
    Haematologia (Budap); 1978-1979; 12(1-4):85-106. PubMed ID: 395046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the knowledge of complement. II. Nephritic factors].
    Leibowitch J; Lesavre P
    Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
    [No Abstract]   [Full Text] [Related]  

  • 12. Membrane attack complex of complement as a pathologic mediator.
    Biesecker G
    Lab Invest; 1983 Sep; 49(3):237-49. PubMed ID: 6193330
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible contribution of the complement system to the inflammatory state.
    Hadding U
    Agents Actions Suppl; 1980; 7():24-32. PubMed ID: 7018199
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complement: function. Biological significance and clinical aspects (author's transl)].
    Brade V
    MMW Munch Med Wochenschr; 1979 Nov; 121(46):1521-6. PubMed ID: 117339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of enhanced complement-dependent cytotoxicity of papain-treated lymphocytes: evidence for increased stability of classical pathway C3 convertase.
    Lublin DM; Grumet FC
    J Immunol; 1982 Feb; 128(2):866-70. PubMed ID: 6915075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent trends in complement research].
    Inai S
    Nihon Rinsho; 1983; 41(4):750-5. PubMed ID: 6350645
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress on complement protein chemistry and the molecular mechanism of activation. Alternative complement pathway].
    Kinoshita T
    Nihon Rinsho; 1988 Sep; 46(9):1894-8. PubMed ID: 3241383
    [No Abstract]   [Full Text] [Related]  

  • 18. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
    J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
    Mold C; Walter EI; Medof ME
    J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
    Fries LF; Friedman HM; Cohen GH; Eisenberg RJ; Hammer CH; Frank MM
    J Immunol; 1986 Sep; 137(5):1636-41. PubMed ID: 3018078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.